Effectiveness of 2% sodium hypochlorite in the endodontic treatment of chronic dentoalveolar abscess
Abstract
Introduction: sodium hypochlorite is used for its wide antibacterial effect and its power to eliminate vital and non-vital tissue.
Objective: to evaluate the effectiveness of 2 % sodium hypochlorite in the endodontic treatment of patients with chronic dentoalveolar abscess.
Methods: quasi-experimental study carried out in Sagua la Grande, between October/2017-June/2019, to a total of 47 adults between 19 and 59 years of age. After etiological corroboration, two groups were formed: 1 (experimental) with 22 patients treated with 2 % sodium hypochlorite and 2 (control) with 25 with 0.9 % saline. At three and seven days, post-treatment, a new clinical evaluation, bacteriological control and surgical technique were carried out. The non-parametric Chi Square test was used (95 % significance level, p<0.05). Ethical precepts were met.
Results: Streptococcus (42.55 %) and Staphylococcus aureus (34.04 %) predominated among the microorganisms. Patients with Staphylococcus aureus presented more clinical manifestations (42.55 %). The stench predominated in both groups (1:27.66 % and 2:23.40 %). With 2 % sodium hypochlorite, it was possible to eliminate a greater number of microorganisms and clinical manifestations after seven days than after 72 hours.
Conclusions: although there were no statistically significant differences between the groups in terms of the presence of microorganisms and the effectiveness of the treatment, clinical changes were observed after treatment in group 1 from 72 hours to seven days, when the germs were almost completely eliminatedDownloads
Published
How to Cite
Issue
Section
License
MediCiego does not apply publication charges. The journal is available in open access without restrictions, in compliance with the international policy on open access to information for the exchange of global knowledge.
The authors will retain their copyright and guarantee the journal the right of first publication of their work. MediCiego is licensed under the Creative Commons Attribution-NonCommercial 4.0 International license (CC BY-NC 4.0) https://creativecommons.org/licenses/by-nc/4.0/deed.es_ES), so it is allowed to copy, reproduce, distribute, publicly communicate the work and generate derivative works, as long as the original author is cited and acknowledged. However, it is not allowed to use the original work for commercial or lucrative purposes.
Authors must sign a copyright agreement through an affidavit of authorship and originality, before publishing.
The authors authorize the publication of their writings; they retain the copyright, and assign to the journal all the rights protected by the Copyright Law that governs Cuba, and implies the edition to disseminate the work.
Likewise, they may establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with the recognition of having been first published in this journal.
Declaration of authorship: download here the Affidavit
